HealthQuill PD-1 inhibitors
FDA has granted full approval for Janssen Biotech’s Balversa drug to treat metastatic bladder cancer after clinical trials showed “significant” improvement in overall survival rates.
Drugs Pharma Research

Pfizer’s experimental drug improves survival rates in hard-to-treat bladder cancer

Bharti Jayshankar January 11, 2024: In a breakthrough for bladder cancer treatment, Pfizer’s experimental anti-PD-1 therapy demonstrated superior efficacy compared to the current.

Read More
Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained free of complications, according to a company statement.
Drugs Health Medical

Pfizer’s trial antibody for type of bladder cancer meets main goal

Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained.

Read More